10 Best Shipping Stocks To Watch Right Now

Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.

NEW YORK (TheStreet) -- Here's what Jim Cramer had to say about some of the stocks callers offered up during the "Mad Money Lightning Round" Friday evening:

CapitalSource (CSE): "I think Bank of America (BAC) is better with more stability. That's where you should be."

DryShips (DRYS): "Have you seen where Nordic American Tanker (NAT) is? Day rates are on the rise and that's where you need to be." Allscripts Healthcare (MDRX): "I think it's OK, but it has had a big spike." Sherwin-Williams (SHW): "I like this one. It's a housing play." Seaspan (SSW): "This is another shipping play. Stick with Nordic American Tanker." Diana Shipping (DSX): "That's the best of the container plays." To read a full recap of "Mad Money" on CNBC, click here. To watch replays of Cramer's video segments, visit the Mad Money page on CNBC. To sign up for Jim Cramer's free Booyah! newsletter with all of his latest articles and videos please click here. -- Written by Scott Rutt in Washington, D.C. To email Scott about this article, click here: Scott Rutt Follow Scott on Twitter @ScottRutt or get updates on Facebook, ScottRuttDC

5 Best New Stocks To Watch For 2015: St. Jude Medical Inc.(STJ)

St. Jude Medical, Inc. develops, manufactures, and distributes cardiovascular and implantable neurostimulation medical devices worldwide. It operates in four segments: Cardiac Rhythm Management, Cardiovascular, Atrial Fibrillation, and Neuromodulation. The Cardiac Rhythm Management segment offers products for cardiac arrhythmias, or irregular heart beats. Its products include tachycardia implantable cardioverter defibrillator systems to provide therapy to patients suffering from lethal heart conditions, such as sudden cardiac arrest; cardiac resynchronization therapy devices to treat heart failure patients; pacemakers to help people whose hearts beat too slowly or who suffer from other cardiac arrhythmias; and leads, which connect devices to the heart and carry the electrical impulses to the heart and information from the heart to the device. The Cardiovascular segment offers mechanical and tissue replacement heart valves, as well as heart valve repair products. It also pr ovides disposable interventional devices, including vascular closure devices, compression assist devices, percutaneous catheter introducers, diagnostic guidewires, and temporary bipolar pacing catheters, as well as diagnostic coronary imaging technology. The Atrial Fibrillation segment offers a system of products for access, diagnosis, visualization, and ablation that assist physicians in diagnosing and treating various irregular heart rhythms used in the electrophysiology lab and cardiac surgery. It provides electrophysiology introducers and catheters, cardiac mapping, navigation and recording systems, and ablation systems. The Neuromodulation segment offers a range of neurostimulation systems, such as rechargeable implantable pulse generators, primary cell implantable pulse generators, and radio frequency powered systems. St. Jude Medical markets its products through a direct sales force and independent distributors. The company was founded in 1976 and is headquartered in St. Paul, Minnesota.

Advisors' Opinion:

• [By Dan Carroll]

  Investors have gotten their money's worth out of Boston Scientific's (NYSE: BSX  ) stock lately. Shares of the medical device maker have surged by more than 30% in the past six months alone, rising higher despite the company's troubles. Sales have fallen into a slump at Boston Scientific, led lower by the company's cardiac rhythm management, or CRM, business, which produces everything from pacemakers to implantable defibrillators. This is an industry on the decline�--�Medtronic (NYSE: MDT  ) , a leader in the medical device field, has seen its own CRM sales slump in recent quarters, while Boston Sci rival St. Jude Medical (NYSE: STJ  ) has similarly had its top line hammered by its CRM division's falling revenue.

• [By Dan Carroll]

  Why is this important? Medtronic's battling with Edwards Lifesciences's (NYSE: EW  ) Sapien heart valve for market share in Europe, and upstarts Boston Scientific (NYSE: BSX  ) and St. Jude Medical (NYSE: STJ  ) are looking to punch into the European industry with their Lotus and Portico valves, respectively. Medtronic's valve-in-valve approval gives the company a leg up on its competition, but is it enough to entrench this firm as a leader in the industry? Motley Fool contributor Dan Carroll and health-care analyst Max Macaluso discuss what you need to know below.

• [By Dan Carroll and Max Macaluso, Ph.D.]

  We're into the heart of earnings season, and several of the medical device industry's biggest players have already reported quarterly results. Johnson & Johnson (NYSE: JNJ  ) led off among the biggest players, with fellow diversified health care firm Abbott Labs (NYSE: ABT  ) and more concentrated company St. Jude Medical (NYSE: STJ  ) following suit last week.

10 Best Shipping Stocks To Watch Right Now: iShares International Select Dividend ETF (IDV)

iShares Dow Jones EPAC Select Dividend Index Fund (the Fund) is an exchange-traded fund that seeks investment results that correspond generally to the price and yield performance of the Dow Jones EPAC Select Dividend Index (the Index). The Index measures the performance of a selected group of equity securities issued by companies that have provided relatively high dividend yields on a consistent basis over time. The Index consists of 100 of the highest dividend-yielding securities (excluding real estate investment trusts (REITs)) in the Dow Jones World Developed-Ex. U.S. Index, an index representative of the Europe, Pacific, Asia and Canada (EPAC) regions, which covers developed markets, excluding the United States. To be included in the Index, the securities must have paid dividends in each of the previous three years; must have a previous year�� dividend per share, which is greater than or equal to its three year average dividend payout ratio; must have a five-year average dividend per share, which is less than or equal to 1.5 times the five-year average dividend payout ratio of the corresponding Dow Jones country index, and must have a minimum three-month average daily trading volume of $3,000,000 a day. The Index is reviewed annually.

The Fund invests in securities of companies that are located in or whose securities are principally traded in the markets of the EPAC regions. The Fund generally will invest at least 90% of its assets in component securities and in depositary receipts representing such securities. The Fund may invest up to 10% of its assets in certain futures, options and swap contracts, cash and cash equivalents, including money market mutual funds. The Fund will only concentrate its investments in a particular industry or group of industries to approximately the same extent that its Index is so concentrated. The Fund�� investment advisor is Barclays Global Fund Advisors. The Fund�� index provider is Dow Jones & Company, Inc. The index provider determines the rel! ative weightings of the securities in the Index and publishes information regarding the market value of the Index.

Advisors' Opinion:

• [By Selena Maranjian]

  Exchange-traded funds offer a convenient way to invest in sectors or niches that interest you. If you'd like to add some international dividend-paying stocks to your portfolio but don't have the time or expertise to hand-pick a few, the iShares Dow Jones International Select Div ETF (NYSEMKT: IDV  ) could save you a lot of trouble. Instead of trying to figure out which companies will perform best, you can use this ETF to invest in lots of them simultaneously.
  
  The basics
  ETFs often sport lower expense ratios than their mutual fund cousins. The iShares ETF's expense ratio -- its annual fee -- is a relatively low 0.50% -- and it recently yielded more than 5%!
  
  This ETF has performed �well, outstripping the MSCI EAFE index over the past three and five years. As with most investments, of course, we can't expect outstanding performances in every quarter or year. Investors with conviction need to wait for their holdings to deliver.

10 Best Shipping Stocks To Watch Right Now: Spectra Energy Partners LP(SEP)

Spectra Energy Partners, LP operates as an investment arm of Spectra Energy Corp. Spectra Energy Partners, LP, through its subsidiaries, engages in the transportation of natural gas through interstate pipeline systems, and the storage of natural gas in underground facilities in the United States. As of December 31, 2007, it owned and operated 100% of the approximately 1,400-mile East Tennessee interstate natural gas transportation system that extends from central Tennessee eastward into southwest Virginia and northern North Carolina, and southward into northern Georgia; and a liquefied natural gas storage facility in Kingsport, Tennessee with working gas storage capacity of approximately 1.1 billion cubic feet (Bcf) and re-gasification capability of 150 million cubic feet per day. The company also owned a 24.5% interest in the approximate 700-mile Gulfstream interstate natural gas transportation system, which extends from Pascagoula, Mississippi, and Mobile, Alabama across the Gulf of Mexico and into Florida; a 50% interest in Market Hub, which owns and operates 2 salt cavern natural gas storage facilities, the Egan storage facility with gas capacity of approximately 20 Bcf, and the Moss Bluff storage facility with working gas capacity of 15 Bcf. The company transports and stores natural gas for local gas distribution companies, municipal utilities, interstate and intrastate pipelines, direct industrial users, electric power generators, marketers, and producers. Spectra Energy Partners (DE) GP, LP, operates as the general partner to Spectra Energy Partners, LP. The company is based in Houston, Texas.

Advisors' Opinion:

• [By David Dittman]

  Question: What�� your medium- and long-term outlook for El Paso Pipeline Partners LP (NYSE: EPB), Energy Transfer Partners LP (NYSE: ETP) and Spectra Energy Partners LP (NYSE: SEP)? If you had to choose one for the long term, which one would it be?

• [By Brian Pacampara]

  What: Shares of Spectra Energy (NYSE: SE  ) climbed 10% today after announcing that it will drop down all U.S. transmission and storage assets to its publicly traded MLP, Spectra Energy Partners (NYSE: SEP  ) .

• [By Rich Duprey]

  The midstream operator announced this week that it is "dropping down" 50% of the pipeline to its master limited partnership, Spectra Energy Partners (NYSE: SEP  ) , for approximately�$555 million�in cash, approximately�$139 million�in newly issued partnership units, and approximately�$129 million�of acquired Express-Platte System debt.�

• [By Rich Duprey]

  Natural gas transportation and storage master limited partnership�Spectra Energy Partners� (NYSE: SEP  ) �announced its 22d consecutive increase in its quarterly dividend payment. Spectra�will pay a�quarterly cash distribution�of $0.50125 on May 15 to the holders of record at the close of business on May 9. That's an increase of five-eighths cent over the previous level of�$0.495�per unit.

10 Best Shipping Stocks To Watch Right Now: LMP Real Estate Income Fund Inc (RIT)

LMP Real Estate Income Fund Inc. (the Fund) is a non-diversified, closed-end management investment company. The Fund�� primary investment objective is to provide high current income. Its secondary investment objective is capital appreciation. Legg Mason Partners Fund Advisor, LLC (LMPFA) is the Fund�� investment manager and AEW Management and Advisors, L.P. (AEW) is the Fund�� subadviser. LMPFA is a wholly owned subsidiary of Legg Mason, Inc.

The Fund invests in securities related to the real estate industry. Its portfolio includes common stocks, preferred stocks and short-term investments. The Fund invests in sectors, such as office, healthcare, diversified, apartments, industrial, shopping centers, home financing, lodging/resorts, regional malls and specialty.

Advisors' Opinion:

• [By GURUFOCUS]

  Special Purpose Funds- Eaton Vance Tax-Adv. Global Dividend Oppor. Fund (ETO) | Yield: 7.3%
  - The Gabelli Global Utility & Income Trust (GLU) | Yield: 6.2%
  - Pimco Global Stocksplus Income Fund (PGP) | Yield: 9.5%
  - LMP Real Estate Income Fund Inc. (RIT) | Yield: 7.0%

• [By Joe Eqcome]

  Actionable Items:

  Highest Positive Spread: Nuveen Mortgage Opportunity Term Fund (JLS)Focus Stock: LMP Real Estate Income Fund (RIT)Last Week's Focus Stock: ASA Gold and Precious Metals (ASA)

  ECB cuts its rates: The European Central Bank (ECB) will cut its benchmark rate a quarter-of-a-point to 0.5%.

10 Best Shipping Stocks To Watch Right Now: Walter Investment Management Corp (WAC)

Walter Investment Management Corp., together with its subsidiaries, is a fee-based business services provider to the residential mortgage industry. The Company is a specialty servicer providing residential loan servicing that focuses on credit-sensitive residential mortgage assets located in the United States. It is also a mortgage portfolio owner and operates an insurance agency serving residential loan customers. The Company operates in four segments: Servicing, Asset Receivables Management (ARM), Insurance, and Loans and Residuals. On July 1, 2011, the Company acquired GTCS Holdings LLC. In November 2012, the Company acquired Reverse Mortgage Solutions, Inc. In January 2013, it acquired originations and capital markets platform of Residential Capital, LLC. In April 2013, the Company announced that its wholly owned subsidiary Reverse Mortgage Solutions, Inc. (RMS) acquired a (Wells Fargo).

Servicing

The Company�� Servicing business segment consists of operations that perform servicing for third-party investors in residential mortgages, manufactured housing and consumer installment loans and contracts, as well as for the Loans and Residuals segment and for the Non-Residual Trusts. During the year ended December 31, 2011, the Company added 259,000 account.

ARM

The Company�� ARM business performs collections of delinquent balances on loans.

Insurance

The Company�� Insurance segment consists of its agency business and its reinsurance businesses. The Company�� Insurance business segment provides voluntary and lender-placed hazard insurance for residential loans, as well as other ancillary products.

Loans and Residuals

The Company's Loans and Residuals business segment consists of the assets and liabilities of the Residual Trusts. It also includes its unencumbered residential loan portfolio and real estate owned.

Advisors' Opinion:

• [By Sean Williams]

  What: Shares of Walter Investment Management (NYSE: WAC  ) , a residential mortgage services provider, jumped as much as 12% after the Federal Housing Finance Agency extended the HARP program for two additional years.

• [By Amanda Alix]

  An immensely profitable enterprise
  With a line-up of willing sellers -- and free of the capital constraints of banks -- mortgage servicers like Nationstar Mortgage (NYSE: NSM  ) , Ocwen Financial (NYSE: OCN  ) , and Walter Investment (NYSE: WAC  ) have seen their stars rise quickly, experiencing stock price surges of at least 100% over the past year.

• [By Christina Rexrode]

  Companies like Nationstar have grown tremendously in recent years by buying the rights to service mortgages from big banks. Ben Chittenden, an analyst at Oppenheimer & Co., estimates that Nationstar, Ocwen Financial Corp. (OCN) and Walter Investment Management (WAC) have grown their combined servicing books from $141 billion in the first quarter of 2011 to $1 trillion in the third quarter of 2013.

10 Best Shipping Stocks To Watch Right Now: Tortoise Pipeline & Energy Fund Inc (TTP)

Tortoise Pipeline & Energy Fund, Inc. (the Fund) is a non-diversified, closed-end management investment company. The Fund�� investment objective is to provide a high level of total return. It focuses to provide stockholders a vehicle to invest in a portfolio consisting of equity securities of pipeline and other energy infrastructure companies. It focuses on pipeline companies, which are engaged in the business of transporting natural gas, natural gas liquids (NGLs), crude oil and refined petroleum products, and on other energy infrastructure companies. It focus invest at least 80% of its total assets in equity securities of pipeline and other energy infrastructure companies. It may invest up to 30% of its total assets in unregistered or otherwise restricted securities, primarily through direct investments in securities of listed companies. Tortoise Capital Advisors, L.L.C. serves as the Fund�� investment adviser. Advisors' Opinion:

• [By Robert Rapier]

  As I write this, Tortoise Pipeline and Energy (NYSE: TTP) trades at a discount of 15.1 percent to its underlying assets, while at the other end of the spectrum Cushing MLP Total Return Fund (NYSE: SRV) trades at a 17.4 percent premium. The average MLP closed-end fund listed trades at a 4.9 percent discount, which is perhaps reasonable given the loss of certain tax advantages and the fact that management fees will eat into returns.

• [By Robert Rapier]

  As I write this, Tortoise Pipeline and Energy (NYSE: TTP) trades at a discount of 15.1 percent to its underlying assets, while at the other end of the spectrum Cushing MLP Total Return Fund (NYSE: SRV) trades at a 17.4 percent premium. The average MLP closed-end fund listed trades at a 4.9 percent discount, which is perhaps reasonable given the loss of certain tax advantages and the fact that management fees will eat into returns.

10 Best Shipping Stocks To Watch Right Now: Organovo Holdings Inc (ONVO)

Organovo Holdings, Inc. (Organovo), formerly Real Estate Restoration & Rental, Inc., incorporated in 2007, is a development-stage company. The Company has developed and is commercializing a platform technology for the generation of three-dimensional (3D) human tissues that can be employed in drug discovery and development, biological research, and as therapeutic implants for the treatment of damaged or degenerating tissues and organs. On December 28, 2011, Real Estate Restoration and Rental, Inc.�� (RERR) entered into an Agreement and Plan of Merger, pursuant to which RERR merged with its, wholly owned subsidiary, Organovo (Merger Sub). On February 8, 2012, the Company merged with and into Organovo Acquisition Corp. (Acquisition Corp.), a wholly owned subsidiary of Organovo, with the Company surviving the merger as a wholly owned subsidiary of Organovo Holdings (the Merger). As a result of the Merger, Organovo acquired the business of Organovo, Inc.

The Company has collaborative research agreements with Pfizer, Inc. (Pfizer) and United Therapeutic Corporation (Unither). As of March 31, 2012, it has five federal grants, including Small Business Innovation Research grants and developed the NovoGen MMX Bioprinter (its first-generation 3D bioprinter). The Company is engaged in the development of specific 3D human tissues to aid Pfizer in discovery of therapies in two areas of interest. In addition, in October 2011, it entered into a research agreement with Unither to establish and conduct a research program to discover treatments for pulmonary hypertension using its NovoGen MMX Bioprinter technology. Additionally, under the research agreement with Unither, the Company granted Unither an option to acquire from the Company a worldwide, royalty-bearing license in certain intellectual property created under the research agreement solely for use in the treatment or prevention of pulmonary hypertension and all other lung diseases.

The Company�� NovoGen MMX Bioprinter is an automate! d device that enables the fabrication of three-dimensional (3D) living tissues comprised of mammalian cells. A custom graphic user interface (GUI) facilitates the 3D design and execution of scripts that direct precision movement of the dispensing heads to deposit cellular building blocks (bio-ink) or supporting hydrogel. The Company is using a third party manufacturer, Invetech Pty., of Melbourne, Australia, to manufacture its NovoGen MMX Bioprinter. Its bioprinting technology and surrounding intellectual property and commercial rights serve as a platform for product generation across multiple markets that employ cell- and tissue-based products and services.

The Company competes with Organogenesis, Advanced BioHealing, Tengion, Genzyme, HumaCyte and Cytograft Tissue Engineering.

Advisors' Opinion:

• [By John Udovich]

  As the the year comes to end, there is still a steady flow of interesting news coming from small cap biotech stocks like Organovo Holdings Inc (NYSEMKT: ONVO), Advanced Cell Technology, Inc (OTCMKTS: ACTC) and TNI BioTech (OTCMKTS: TNIB)�plus still largely private biotech companies like Genocea Biosciences (NASDAQ: GNCA), Retrophin (OTCMKTS: RTRX), Auspex Pharmaceuticals (NASDAQ: ASPX) and GlycoMimetics (NASDAQ: GLYC) who have filed to become the next potentially hot biotech IPOs���presumably some time early�next year. Just consider the following biotech news: